FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Histrelin Acetate Implant
Status: Discontinuation
»Therapeutic Categories: Oncology

Endo Pharmaceuticals, Inc. (Revised 09/21/2021)

Company Contact Information:

Presentation Posting Date Related Information
Vantas 50 mg Implantation Kit (NDC 67979-500-01) 09/21/2021 Endo has made a business decision to discontinue manufacture of this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English